Four former senior executives and accountants at the British subsidiary of an Indiana-based manufacturer of medical devices and aerospace products were charged by the SEC for their roles in an accounting fraud that was so pervasive that it distorted the financial statements of the parent company. The SEC also reached settlements with the company’s former CEO and current CFO, who were not involved or aware of the scheme at the subsidiary.
SEC Charges Former Executives and Accountants With Fraud at British Subsidiary of Medical Devices Company